Capabilities · Liquid dosage forms

Suspensions & emulsions

A proposed service scope for dispersed liquid systems, addressing particle suspension, phase emulsification, homogeneity controls and filling requirements.

PlannedCatalogue scope

Illustrative unbranded dropper bottle neck detail.
Illustrative unbranded dropper bottle neck detail. It does not depict Luang Pharma's project, products or installed equipment.

Service statusPlanned

Planned.

Technical boundaries and readiness need confirmation before an activity could be presented as available.

Basis · Catalogue scope

Status
PlannedNo available service asserted
Source-plan relationship
Catalogue scopeProposed catalogue expansion
Readiness
Not establishedProduct and process evidence needed
Facility roadmap
First commercial batch target Q1 2028 · indicativeNot a service date

01 · Proposed service scope

Start with the product and its container.

Suspensions and emulsions are presented as a planned service domain. The specific particulate characteristics, phase boundaries and physical stability profiles would determine the processing scope.

The initial Boten production plan specifies parenteral formats and raw materials. Dispersed liquid systems fall outside this initial framework and would need separate scope evaluation before any implementation.

Maintaining uniform particle distribution and preventing phase separation are distinct technical challenges. Presenting these formats together does not imply a single mixing approach would suit every preparation.

Catalogue boundary

A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.

02 · Presentation families

Match the route to the format.

Planned formats and their source relationship
FormatPlanning noteBasisStatus
Oral suspensionsProposed solid-in-liquid dispersions; would require separate technical review and scope confirmation.Catalogue scopePlanned
Liquid emulsionsBiphasic liquid preparations fall outside the initial project plan and require distinct evaluation.Catalogue scopePlanned
Dispersible powders for suspensionPowders & granulesDry formulations intended for liquid reconstitution; would need separate handling assessments.Catalogue scopePlanned

03 · Process scope for discussion

Make the sequence and its evidence visible.

01 · Process stage

Planned

Component and phase preparation

Define the physical characteristics of dispersed materials and the required continuous phase parameters.

02 · Process stage

Planned

High-shear mixing assessment

Consider appropriate mechanical sheer rates, thermal controls and vessel configurations for the specific dispersion.

03 · Process stage

Planned

Homogenisation and stabilisation

Determine the specific physical controls needed to maintain droplet size or uniform particle distribution.

04 · Process stage

Planned

In-process homogeneity verification

Define the sampling strategy and acceptance criteria required to confirm uniform material distribution.

05 · Process stage

Planned

Agitated filling controls

Establish the necessary holding tank agitation and recirculation parameters during the packaging operation.

06 · Process stage

Planned

Physical stability testing interfaces

Connect the manufacturing record to relevant sedimentation, rheology and phase separation analytical results.

Illustrative sequence

This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.

04 · Supporting services

No service stands alone.

01PlannedCatalogue scope

Process development & scale-up

Process definition, scale considerations and the evidence needed for transfer.

Explore proposed scope

02PlannedCatalogue scope

Analytical method development

Product-specific test methods and analytical development questions.

Explore proposed scope

03PlannedCatalogue scope

Technology transfer

Product knowledge, process information and responsibilities for a proposed transfer.

Explore proposed scope

05 · Readiness questions

A service claim needs a defined evidence base.

Formulation and phase data
Exact particle characteristics, required mixing conditions and physical stability profiles.
Equipment and processing systems
Relevant installed homogenisers, agitated holding vessels and an approved scope.
Homogeneity evidence
Defined mixing parameters, appropriate uniformity validation and necessary physical controls.
Analytical responsibilities
Controlled rheological testing, relevant analytical scope and defined review rights.
Regulatory context
Applicable facility permissions and product authorisations for the specific dispersion.
Technical agreement
Responsibilities, defined data exchange mechanisms and boundaries for any engagement.

06 · Practical questions

Before a technical discussion.

Is this service currently available?

No. The service is Planned. This text is a scope proposal and does not represent an operating suspension or emulsion line.

Are dispersed systems part of the initial Boten plan?

No. The initial plan is structured around specific sterile presentations and proteins. Suspensions and emulsions are catalogue proposals needing distinct scope confirmation.

What information helps define the question?

Detail the proposed formulation, particle or droplet size requirements, development stage, target market and the processing question. Confidential data should follow an agreed route.

Is there a service launch quarter?

No. No service-specific quarter is established for dispersed liquids. Project-wide indicative milestones do not commit any catalogue scope to a specific date.

Does a technical discussion establish supply?

No. Feasibility, specific equipment scope, facility permissions, process evidence and technical agreements would need to be established before any service commitment.

Back to capabilities

Professional enquiries

Discuss a defined question.

Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.

Contact Luang Pharma